| RS118204113 |
HMBS
|
Health Risk |
Likely pathogenic |
— |
| RS118204114 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204115 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204116 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204117 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204119 |
HMBS
|
Health Risk |
Pathogenic |
Encephalopathy, porphyria-related |
| RS118204120 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, HMBS-related disorder |
| RS1182043656 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 4 |
| RS118204425 |
ALDOB
|
Health Risk |
Pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS118204426 |
ALDOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS118204428 |
ALDOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS118204429 |
ALDOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary fructosuria, Inborn genetic diseases |
| RS118204435 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204437 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204438 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204439 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204440 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204441 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204442 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204443 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204444 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204446 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204447 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204448 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204449 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS118204450 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS118204451 |
NHEJ1
|
Health Risk |
Pathogenic |
Cernunnos-XLF deficiency, Cernunnos-XLF deficiency |
| RS118204452 |
NHEJ1
|
Health Risk |
Pathogenic |
Cernunnos-XLF deficiency, Cernunnos-XLF deficiency |
| RS118204453 |
NHEJ1
|
Health Risk |
Pathogenic |
Cernunnos-XLF deficiency, Cernunnos-XLF deficiency |
| RS118204454 |
F12
|
Health Risk |
Pathogenic |
FACTOR XII (LOCARNO), FACTOR XII (LOCARNO) |
| RS118204456 |
F12
|
Health Risk |
Pathogenic |
Hereditary angioedema type 3, Hereditary angioneurotic edema |
| RS1182086058 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS1182090591 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1182102272 |
SLC37A4
|
Health Risk |
Likely pathogenic |
Glucose-6-phosphate transport defect, Phosphate transport defect |
| RS1182103005 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1182112270 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1182146385 |
SBF1
|
Health Risk |
Pathogenic |
— |
| RS1182148645 |
NFKB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, common variable |
| RS1182150046 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS1182156737 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1182162593 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS1182165362 |
MCOLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS1182196436 |
DSG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Palmoplantar keratoderma i, striate |
| RS1182199373 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS1182199981 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1182209513 |
SLC12A6
|
Health Risk |
Likely pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Agenesis of the corpus callosum with peripheral neuropathy |
| RS1182227611 |
TTN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1182234844 |
UROD
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1182235762 |
TCIRG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS1182240785 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1182262187 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1182277140 |
LCA5
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1182278359 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS1182279478 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1182283562 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS1182285073 |
ETHE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS1182312612 |
PNPLA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive congenital ichthyosis 10, Congenital ichthyosiform erythroderma |
| RS1182317785 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1182325800 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1182326570 |
FBXL4
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 13, Inborn genetic diseases |
| RS1182330004 |
IFT80
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1182347499 |
OCA2
|
Health Risk |
Likely pathogenic |
— |
| RS1182353109 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1182354883 |
MECP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS1182383020 |
NGLY1
|
Health Risk |
Pathogenic |
Congenital disorder of deglycosylation, Congenital disorder of deglycosylation |
| RS1182383626 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1182409555 |
ADAMTS2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS1182409968 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1182423172 |
RTEL1
|
Health Risk |
Likely pathogenic |
— |
| RS1182434832 |
SEC24D
|
Health Risk |
Pathogenic |
Cole-Carpenter syndrome 2, Cole-Carpenter syndrome 2 |
| RS1182444882 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1182447072 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1182448951 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Cardiovascular phenotype |
| RS1182475940 |
SCNN1B
|
Health Risk |
Likely pathogenic |
Pseudohypoaldosteronism, type IB1 |
| RS1182488370 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1182502058 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 1 |
| RS1182508823 |
TCIRG1
|
Health Risk |
Pathogenic |
— |
| RS1182521445 |
PIGB
|
Health Risk |
Pathogenic |
— |
| RS1182545971 |
RORB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1182566703 |
GATA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tetralogy of Fallot, Atrioventricular septal defect 4 |
| RS1182592818 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS1182595182 |
NDUFS6
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 9 |
| RS1182598654 |
NRL
|
Health Risk |
Pathogenic |
— |
| RS1182603872 |
GCK
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Inborn genetic diseases, Maturity-onset diabetes of the young |
| RS1182614290 |
DNAJB2
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS1182635980 |
MTHFR
|
Health Risk |
Pathogenic/Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS1182648647 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1182648920 |
F9
|
Health Risk |
Pathogenic |
Thrombophilia, X-linked |
| RS1182653117 |
SLC12A3
|
Health Risk |
Pathogenic |
— |
| RS1182670238 |
HGD
|
Health Risk |
Pathogenic/Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS1182676302 |
SCO2
|
Health Risk |
Likely pathogenic |
Cardioencephalomyopathy, fatal infantile |
| RS1182690810 |
DNAH1
|
Health Risk |
Pathogenic |
Spermatogenic failure 18, Ciliary dyskinesia |
| RS1182705193 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1182741031 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Nephrolithiasis/nephrocalcinosis |
| RS1182743416 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS1182748194 |
PCARE
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1182781290 |
TJP2
|
Health Risk |
Likely pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS1182790091 |
BCS1L
|
Health Risk |
Likely pathogenic |
Pili torti-deafness syndrome, GRACILE syndrome |
| RS1182802068 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary hypertension, neonatal |
| RS1182803771 |
CAPN10
|
Health Risk |
Pathogenic |
— |